RxDoctor Payments Data

Padma Ponugoti, MD

Ophthalmology · Terre Haute, INNPI 1952419004

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,708 of the $5,745 with a category attached, or 81.9%. 25 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 30.0% of the total. Reporting peaked in 2019 at $2,060 and has fallen 70.7% since, to $603 in 2025.

$5,745in general payments, 2019–2025

Across 106 payments — averaging $54.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Surgical Vision, Inc.$2K
  • Alcon$1K
  • AbbVie$644
  • Lensar, Inc.$289
  • Eyepoint US, Inc.$173
  • Novartis$162
  • plus $1K from 19 others

What the payments were for

  • Travel & lodging$1,03818%
  • Food & beverage$4,70882%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,745 in reported general payments places this provider in the 85th percentile of 266 ophthalmology providers in Indiana.

See all ophthalmology providers in Indiana

Medicare billing

Part B allowed, 2024
$146,250
Medicare patients
212
Services billed
1,088

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate367$9,492
Diclofenac Sodium348$3,824
Ofloxacin351$3,697
Ketorolac Tromethamine46$883
Latanoprost13$30

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Terre Haute

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →